People with chronic illnesses at high risk of severe disease will be eligible for vaccination from 24 March. Businesses with 10 or more employees must test....
Moderna announced yesterday that they have begun administering their COVID-19 vaccine, mRNA-1273, to the first participants in the Phase 2/3 study called the KidCOVE.